NCT07389655 · NOT YET RECRUITING

(MAP) Pilot Randomized Controlled Trial for Older Adults With Mild Cognitive Impairment and Elevated Stress

This pilot study tests whether a tailored mindfulness program can lower stress and support memory, mood, and well-being in older adults with mild cognitive impairment (MCI) and high stress. It is compared with a health education program. A pilot is a small early study, mainly checking feasibility, not proof that it works.

Eligibility criteria

Inclusion Criteria:
* MCI participant: Community-dwelling, ≥65 years old, and diagnosed with MCI within the past 12 months, consented to participate in the trial, and have Wi-Fi access; Diagnosed with chronic stress-related conditions based on ICD-10 codes. No prior experience in mindfulness or other mind-body practices (e.g., yoga, Qi Gong, and Tai Chi) within the past year for >10 minutes per day28.
If taking medications with significant cholinergic, anticholinergic effects, anti-depressants, corticosteroid, or non-steroidal anti-inflammatory drug (NSAID), stabilized dose for ≥6 months.
* Ability to speak and read English
* Ability to provide informed consent
Exclusion Criteria:
* Diagnosed major psychiatric disorder, e.g., psychosis, bipolar disorder, and schizophrenia.Those with depression and anxiety will not be excluded, as they may be the prime targets for such an intervention and to avoid floor effects on measures that we suspected with our previous trial.
Diagnosed major neurological disorders, e.g., large vessel stroke, brain tumor, and severe brain injury.
Diagnosed terminal illness, including cancer, requiring palliative care, and organ failure, including hepatic or renal failure.
Sensory impairment, e.g., visual/hearing impairment impacting abilities to participate in the study.
Participating in other intervention(s) concurrently, either a research study or for self-interest (e.g., lifelong learning programs).which may improve memory for >2 days/week, 30 minutes a session in the past 3 months. After a wash-out period of ≥6 months, potential participants will be allowed to join this present study.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials